Works by Takeoka, Sawa


Results: 3
    1
    2
    3

    Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 4, p. 608, doi. 10.1007/s10637-017-0527-z
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Shiroyama, Takayuki;
    • Takeoka, Sawa;
    • Naito, Yujiro;
    • Omachi, Naoki;
    • Kimura, Yohei;
    • Morishita, Naoko;
    • Suzuki, Hidekazu;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article